Myeloma treatment combo sees 100% response rate in trial
Combination treatment with Tecvayli (teclistamab-cqyv) and Darzalex…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreCombination treatment with Tecvayli (teclistamab-cqyv) and Darzalex…
When my mum, Esther, was diagnosed with myeloma…
I recently went to the supermarket to pick up…
Over a 15-year period, the median survival time for…
It started like any ordinary ache — something my…
The first time I saw a patient all by…